Cellular senescence, p21, and the path to fibrosis.
Abstract
Senescent cells secrete bioreactive molecules that promote disease, fibrosis, and aging, yet the molecular mechanisms driving the production of these secreted factors remain incompletely understood. In this issue, Papismadov et al (2024) report that p21 (CDKN1A), known to activate the senescence growth arrest, also regulates expression of extracellular matrix components that promote fibrosis, thereby revealing new therapeutic inroads to target fibrosis and age-related pathologies.
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
The paper addresses the role of cellular senescence and its molecular mechanisms, specifically focusing on p21 and its regulation of extracellular matrix components that contribute to fibrosis. This is relevant to longevity research as it explores the underlying processes that drive age-related pathologies, potentially offering therapeutic targets for mitigating the effects of aging. However, while the findings are solid and contribute to the understanding of senescence and fibrosis, they do not represent a major breakthrough or transformative implications for the field, hence the moderate impact score.
Author of this paper? Send a correction.